Bitcoin pioneer Charlie Shrem peels back the layers on the lives and backgrounds of the world's most impactful innovators. Centering around intimate narratives, Shrem uncovers a detailed, previously unspoken story of the genesis and evolution of bitcoin, cryptocurrency, artificial intelligence, and the web3 movements. Join Shrem as he journeys through the uncharted territories of tech revolutions, revealing the human side of the stories that shaped the digital world we live in today.
…
continue reading
Contenido proporcionado por Harvard Innovation Labs. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Harvard Innovation Labs o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !
¡Desconecta con la aplicación Player FM !
Harvard Innovation Labs Stories: David Raiser - Aldatu Biosciences
M4A•Episodio en casa
Manage episode 177804574 series 1211262
Contenido proporcionado por Harvard Innovation Labs. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Harvard Innovation Labs o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
David Raiser is the CEO and co-founder of Aldatu Biosciences, a company that has developed drug resistance diagnostics for HIV patients. Raiser holds a Ph.D. in Genetics from Harvard Medical School, while his co-founder and Aldatu's CSO Iain MacLeod has a plethora of degrees — including a Ph.D. in Pathology from the University of Cambridge— as well as an academic appointment at the Harvard School of Public Health AIDS Initiative. Together, the pair is leading a push for better, more affordable diagnostics tools, not only for HIV-related applications but also for other infectious diseases, in order to improve the quality of patient care and the cost of healthcare.
…
continue reading
12 episodios
M4A•Episodio en casa
Manage episode 177804574 series 1211262
Contenido proporcionado por Harvard Innovation Labs. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Harvard Innovation Labs o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
David Raiser is the CEO and co-founder of Aldatu Biosciences, a company that has developed drug resistance diagnostics for HIV patients. Raiser holds a Ph.D. in Genetics from Harvard Medical School, while his co-founder and Aldatu's CSO Iain MacLeod has a plethora of degrees — including a Ph.D. in Pathology from the University of Cambridge— as well as an academic appointment at the Harvard School of Public Health AIDS Initiative. Together, the pair is leading a push for better, more affordable diagnostics tools, not only for HIV-related applications but also for other infectious diseases, in order to improve the quality of patient care and the cost of healthcare.
…
continue reading
12 episodios
كل الحلقات
×Bienvenido a Player FM!
Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.